BIO (June 2025)/ XFTTBIOCMEGL / CME EMini
BIO- - | Chg. - | Open | High | Low | Previous Close |
---|---|---|---|---|---|
-USD | - | - | - | - | - |
Newsfile Corp
1:10 AM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securiti...
GlobeNewswire
12:55 AM
bluebird bio, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 20...
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
DEADLINE ALERT for PLUG, EVLV, BLUE, LUNA: Law Offices of Howard G. Smith Reminds Investors of Class...
GlobeNewswire
05-01
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
GlobeNewswire
05-01
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives
GlobeNewswire
05-01
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merge...
GlobeNewswire
05-01
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merge...
GlobeNewswire
05-01
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
GlobeNewswire
04-30
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of...
GlobeNewswire
04-30
BLUE LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire ...
GlobeNewswire
04-30
Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated...
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-29
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
04-29
GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmu...
GlobeNewswire
04-27
ROSEN, LEADING INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities ...
GlobeNewswire
04-26
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiativ...
GlobeNewswire
04-25
GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
GlobeNewswire
04-24
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses o...
GlobeNewswire
04-24
noco-noco Collaborates with Binex to Develop Agriculture Based, Soil Sequestered Carbon into Credits